P

Inventor

DOUTY BRENT

US25 patents
⚠️ This page may combine multiple inventors who share the name “DOUTY BRENT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

24 patents
US9707233B2Jul 18, 2017

Heterocyclylamines as PI3K inhibitors

INCYTE CORP23 citations98
US10138248B2Nov 27, 2018

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

INCYTE CORP36 citations94
US10092570B2Oct 9, 2018

Heterocyclylamines as PI3K inhibitors

INCYTE CORP17 citations94
US9918990B2Mar 20, 2018

Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors

INCYTE CORP23 citations94
US9730939B2Aug 15, 2017

Heterocyclylamines as PI3K inhibitors

INCYTE CORP23 citations94
US9399640B2Jul 26, 2016

Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors

INCYTE CORP37 citations94
US10376513B2Aug 13, 2019

Heterocyclylamines as PI3K inhibitors

INCYTE CORP12 citations93
US11433071B2Sep 6, 2022

Heterocyclylamines as PI3K inhibitors

INCYTE CORP3 citations84
US10975088B2Apr 13, 2021

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

INCYTE CORP6 citations84
US10738057B2Aug 11, 2020

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP5 citations84
US10479795B2Nov 19, 2019

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

INCYTE CORP13 citations84
US9932341B2Apr 3, 2018

Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders

INCYTE CORP9 citations84
US11780840B2Oct 10, 2023

Tricyclic urea compounds as JAK2 V617F inhibitors

INCYTE CORP4 citations74
US11926630B2Mar 12, 2024

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP2 citations73
US11819505B2Nov 21, 2023

Heterocyclylamines as PI3K inhibitors

INCYTE CORP1 citations73
US11225486B2Jan 18, 2022

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP4 citations73
US11186580B2Nov 30, 2021

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

INCYTE CORP4 citations73
US11046658B2Jun 29, 2021

Aminopyrazine derivatives as PI3K-γ inhibitors

INCYTE CORP4 citations72
US12152033B2Nov 26, 2024

Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders

INCYTE CORP0 citations63
US12516065B2Jan 6, 2026

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP0 citations62
US12421197B2Sep 23, 2025

Aminopyrazine derivatives as PI3K-γ inhibitors

INCYTE CORP0 citations62
US12173006B2Dec 24, 2024

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

INCYTE CORP1 citations62
US12030885B2Jul 9, 2024

Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors

INCYTE CORP0 citations62
US11661422B2May 30, 2023

Tricyclic urea compounds as JAK2 V617F inhibitors

INCYTE CORP1 citations62

LI YUN-LONG

1 patent